RANDOMIZED TRIALS DIFFICULT FOR INTERVENTIONAL NEURORADIOLOGY BALLOONS, COILS, LIQUID OCCLUSIVES, PANEL SAYS; QUANTITATIVE OUTCOME MEASURES SUGGESTED
This article was originally published in The Gray Sheet
Executive Summary
Quantitative outcome measures are needed in clinical trials studying balloons, coils, and liquid occlusives used to treat aneurysms, arteriovenous malformations, or bleeding in the cerebrovascular circulation, members of FDA's Neurological Devices Advisory Panel stressed at a Sept. 15 meeting in Rockville, Maryland.